Kürschner Gerrit, Zhang Qingzhou, Clima Rosanna, Xiao Yi, Busch Jonas Felix, Kilic Ergin, Jung Klaus, Berndt Nikolaus, Bulik Sascha, Holzhütter Hermann-Georg, Gasparre Giuseppe, Attimonelli Marcella, Babu Mohan, Meierhofer David
Max Planck Institute for Molecular Genetics, Mass Spectrometry Facility, Berlin, Germany.
Technical University of Berlin, Institute of Bioanalytics, Department of Biotechnology, Berlin, Germany.
Oncotarget. 2017 Nov 11;8(62):105882-105904. doi: 10.18632/oncotarget.22413. eCollection 2017 Dec 1.
Renal oncocytomas are rare benign tumors of the kidney and characterized by a deficient complex I (CI) enzyme activity of the oxidative phosphorylation (OXPHOS) system caused by mitochondrial DNA (mtDNA) mutations. Yet, little is known about the underlying molecular mechanisms and alterations of metabolic pathways in this tumor. We compared renal oncocytomas with adjacent matched normal kidney tissues on a global scale by multi-omics approaches, including whole exome sequencing (WES), proteomics, metabolomics, and metabolic pathway simulation. The abundance of proteins localized to mitochondria increased more than 2-fold, the only exception was a strong decrease in the abundance for CI subunits that revealed several pathogenic heteroplasmic mtDNA mutations by WES. We also observed renal oncocytomas to dysregulate main metabolic pathways, shunting away from gluconeogenesis and lipid metabolism. Nevertheless, the abundance of energy carrier molecules such as NAD, NADH, NADP, ATP, and ADP were significantly higher in renal oncocytomas. Finally, a substantial 5000-fold increase of the reactive oxygen species scavenger glutathione can be regarded as a new hallmark of renal oncocytoma. Our findings demonstrate that renal oncocytomas undergo a metabolic switch to eliminate ATP consuming processes to ensure a sufficient energy supply for the tumor.
肾嗜酸细胞瘤是一种罕见的肾脏良性肿瘤,其特征是由线粒体DNA(mtDNA)突变导致氧化磷酸化(OXPHOS)系统的复合物I(CI)酶活性缺陷。然而,对于该肿瘤潜在的分子机制和代谢途径改变知之甚少。我们通过多组学方法,包括全外显子测序(WES)、蛋白质组学、代谢组学和代谢途径模拟,在全球范围内将肾嗜酸细胞瘤与相邻的匹配正常肾组织进行了比较。定位于线粒体的蛋白质丰度增加了2倍以上,唯一的例外是CI亚基的丰度大幅下降,WES揭示了几种致病性异质性mtDNA突变。我们还观察到肾嗜酸细胞瘤会使主要代谢途径失调,从糖异生和脂质代谢转向其他途径。尽管如此,肾嗜酸细胞瘤中能量载体分子如NAD、NADH、NADP、ATP和ADP的丰度显著更高。最后,活性氧清除剂谷胱甘肽的丰度大幅增加5000倍可被视为肾嗜酸细胞瘤的一个新标志。我们的研究结果表明,肾嗜酸细胞瘤会发生代谢转换,以消除消耗ATP的过程,从而确保为肿瘤提供足够的能量供应。